The Journal of Hematology Oncology Pharmacy is an independent, peer-reviewed journal founded in 2011 to provide hematology and oncology pharmacy practitioners and other healthcare professionals with high-quality peer-reviewed information relevant to hematologic and oncologic conditions to help them optimize drug therapy for patients.
Journal of Hematology Oncology Pharmacy
Patrick J. Medina, PharmD, BCOP1; Val R. Adams, PharmD, BCOP, FCCP2
1Associate Professor, Dept of Pharmacy, University of Oklahoma College of Pharmacy, Oklahoma City; 2Associate Professor, Pharmacy, and Program Director, PGY2, Specialty Residency Hematology/Oncology, University of Kentucky College of Pharmacy, Lexington
The Journal of Hematology Oncology Pharmacy (JHOP) seeks to provide hematology and oncology pharmacy practitioners and other hematology oncology professionals with high-quality peerreviewed information to help them optimize drug therapy for patients.
Original Research provides an outlet for translational and practice-based research, including case reports and case series. Our goal for this section is that these articles will answer the clinically relevant pharmacy questions that remain unaddressed. Many of which do not require a million-dollar extramural grant to answer, but that does not diminish the quality of the questions or the answers.
Review Articles include manuscripts focusing on drugs and disease states and on basic science reviews regarding the complex molecular biology of cancer. Although there is a plethora of review articles available to clinicians, most do not have a pharmacy focus, and few if any focus on the molecular biology of cancer and the complex signaling pathways associated with malignancy. As new classes of drugs emerge (eg, BRAF in hibitors), discussion about the pathways and the drugs targeting the pathways will help pharmacists understand the drug classes based on the pharmacology of these agents.
As pharmacy practice and research become integral to improving the clinical care of cancer patients as well as to expanding the research literature in contemporary oncology pharmacy, new avenues are necessary to ensure this information gets disseminated to the profession.
We as the co-editors-in-chief hope that this journal will fill many unmet needs by providing another avenue for the publication of peer-reviewed, high-quality pharmacy literature that is focused for hematology oncology practitioners. We encourage you to submit manuscripts for consideration and to provide your feedback on what would enhance the value of this publication for you and your colleagues.